Skip to main content
Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
2.850
+0.010 (0.35%)
At close: Dec 20, 2024, 4:00 PM
3.000
+0.150 (5.26%)
After-hours: Dec 20, 2024, 7:57 PM EST

Perspective Therapeutics Revenue

Perspective Therapeutics had revenue of $369.00K in the quarter ending September 30, 2024, with 33.70% growth. This brings the company's revenue in the last twelve months to $1.56M, down -351.13% year-over-year. In the year 2023, Perspective Therapeutics had annual revenue of $1.43M, down -73.52%.

Revenue (ttm)
$1.56M
Revenue Growth
-351.13%
P/S Ratio
98.37
Revenue / Employee
$13,084
Employees
119
Market Cap
192.62M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.43M-3.98M-73.52%
Dec 31, 20225.42M--
Jun 30, 2022---
Jun 30, 202110.05M373.00K3.85%
Jun 30, 20209.68M2.37M32.35%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inogen 331.52M
MacroGenics 141.33M
Inventiva 20.65M
Fate Therapeutics 13.45M
Verastem 10.00M
Molecular Partners AG 7.11M
Akso Health Group 2.41M
Inhibrx Biosciences 1.57M
Revenue Rankings

CATX News

More News